SCHEMBL6318124

SCHEMBL6318124

CCOC(=O)Cc1c(C)c(C#N)c2nc3ccccn3c2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 5/20 0.43
HPGD P15428 5/20 0.43
GAA P10253 4/20 0.43
HSD17B10 Q99714 3/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 2/20 0.42
RXFP1 Q9HBX9 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GLA P06280 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310328 0.84 NPSR1 (0.44) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6311689 0.83 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6312086 0.81 MAPT (0.47) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6310501 0.81 KDM4E (0.36) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6311562 0.80 HPGD (0.43) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6310742 0.80 HPGD (0.43) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6311004 0.79 ENPP2 (0.43) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL6311104 0.79 ENPP2 (0.41) ALDH1A1KDM4EHPGDMAPK1RXFP1
SCHEMBL6312786 0.78 KDM4E (0.44) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL6317979 0.77 ADORA3 (0.43) ALDH1A1KDM4EHPGDGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885KDM4E 3360/4885HPGD 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.